Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann

Showing results (241-250 of 23,833) with videos related to

Pageof 2,384
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|October 30, 2003
Renal therapeutics: patent highlights January to June 2003Hermann A Mucke
Expert Opinion on Drug Discovery|March 15, 2013
Genomics and proteomics are changing discovery, development and clinical use of dementia drugsHermann Am Mucke
The Surgical Clinics of North America|December 1, 1990
Surgery for acute and chronic cholecystitisR E Hermann
Angewandte Chemie (International Ed. in English)|March 31, 2012
Azobenzenes in a new light-switching in vivoHermann A Wegner
Cancer Research|January 1, 1977
Two-stage control of cell proliferation induced in rat liver by alpha-hexachlorocyclohexaneR Schulte-Hermann
Bio Systems|October 19, 2005
The generalized flux-minimization method and its application to metabolic networks affected by enzyme deficienciesHermann-Georg Holzhütter
Pharmaceutical Patent Analyst|December 9, 2017
Patent highlights August-September 2017Hermann Am Mucke
Drugs & Aging|November 22, 2000
Optimising therapy for insulin-treated type 2 diabetes mellitusL S Hermann
Epilepsia|January 1, 1993
Developing a model of quality of life in epilepsy: the contribution of neuropsychologyB P Hermann
Medical Hypotheses|June 1, 1979
Psychopathology in epilepsy and learned helplessnessB P Hermann
Pageof 2,384

Showing results (241-250 of 23,833) with videos related to

Sort By:
Pageof 2,384
Current Opinion in Investigational Drugs (London, England : 2000)|October 30, 2003
Renal therapeutics: patent highlights January to June 2003Hermann A Mucke
Expert Opinion on Drug Discovery|March 15, 2013
Genomics and proteomics are changing discovery, development and clinical use of dementia drugsHermann Am Mucke
The Surgical Clinics of North America|December 1, 1990
Surgery for acute and chronic cholecystitisR E Hermann
Angewandte Chemie (International Ed. in English)|March 31, 2012
Azobenzenes in a new light-switching in vivoHermann A Wegner
Cancer Research|January 1, 1977
Two-stage control of cell proliferation induced in rat liver by alpha-hexachlorocyclohexaneR Schulte-Hermann
Bio Systems|October 19, 2005
The generalized flux-minimization method and its application to metabolic networks affected by enzyme deficienciesHermann-Georg Holzhütter
Pharmaceutical Patent Analyst|December 9, 2017
Patent highlights August-September 2017Hermann Am Mucke
Drugs & Aging|November 22, 2000
Optimising therapy for insulin-treated type 2 diabetes mellitusL S Hermann
Epilepsia|January 1, 1993
Developing a model of quality of life in epilepsy: the contribution of neuropsychologyB P Hermann
Medical Hypotheses|June 1, 1979
Psychopathology in epilepsy and learned helplessnessB P Hermann
Pageof 2,384